Medicines May Soon Come with Braille Labels, Audio QR Codes

New Delhi: India’s drug regulatory authority is considering having braille cards and voice-assisted QR codes on medicine strips to make them patient friendly. The regulatory body has invited public comments for further action.

Earlier, the regulatory body had received representations regarding problems being faced by blind or visually impaired people to read medicines, tablet/capsule strips.

“These special peoples face difficulty to know the name and expiry of the medicines and depend on others therefore, it was requested that a provision under Drugs and Cosmetics Act and Rules to label the drugs with braille inscriptions be inserted,” people in the know told ET.

The matter was then deliberated by the Drugs Consultative Committee (DCC) meeting in 2020 which recommended constituting a sub- committee to examine the issue in detail for further consideration.

The sub-committee which was constituted on DCC’s recommendation had submitted its report, recommending support in the ease of access of medication to the visually impaired persons, the guideline regarding additional labelling in braille language was proposed to be implemented “initially on voluntary basis” for the drugs, which are supplied in mono carton pack size.

It was also recommended that consideration should be given to medicinal products likely to be used by a high visually impaired target population, e.g. certain eye drop preparations.

It was also advised that the braille labels would not be applicable for the products dispensed or given under supervision of health care professional’s e.g. injectable, vaccine etc.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices